trastuzumab deruxtecan
daiichi sankyo,astrazeneca
[]
although i think other abstracts would have deserved one throughout the years, an asco plenary session standing ovation really is something special! #tdxd #asco22
Med onc and hematologist at @chudequebec with focus on lung cancer. Tweets in English for sake of conversation, mais toujours heureux de parler français!